Among Men Living With Early, Untreated Prostate Cancer, Study Finds Acceptable Levels Of Anxiety

Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study’s results suggest that living with Read more…

Review Provides New Insights Into The Causes Of Anorexia

New imaging technology provides insight into abnormalities in the brain circuitry of patients with anorexia nervosa (commonly known as anorexia) that may contribute to the puzzling symptoms found in people with the eating disorder. In a review paper published on line in Nature Reviews Neuroscience, Walter Kaye, MD, professor of psychiatry and director of the Eating Disorders Program at the University of California, San Diego, and Read more…

More Loneliness, Anxiety Experienced By Overweight Kids, MU Study Finds

As childhood obesity rates continue to increase, experts agree that more information is needed about the implications of being overweight as a step toward reversing current trends. Now, a new University of Missouri study has found that overweight children, especially girls, show signs of the negative consequences of being overweight as early as kindergarten.
"We found that both boys and girls who were overweight from kindergarten Read more…

What Is Mental Health? What Is Mental Disorder?

Mental health refers to our cognitive, and/or emotional wellbeing - it is all about how we think, feel and behave. Mental health, if somebody has it, can also mean an absence of a mental disorder. Approximately 25% of people in the UK have a mental health problem during their lives. The USA is said to have the highest incidence of people diagnosed with mental health problems in the developed world. Your mental health Read more…

New Animal Study Of Rexahn’s Serdaxin™ Shows Drug’s Promise To Treat Anxiety And Depression With Minimal Side Effects

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), announced the results of a wide-ranging animal study offering more evidence that Serdaxin™ may be an effective therapeutic for the treatment of anxiety disorders in humans. Serdaxin is Rexahn’s leading anxiety and depression drug candidate, and is currently in Phase II clinical trials.
The research tested Clavulanic Read more…